Equifax Cash & Equivalents increased by 1.4% to $183.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.0%, from $195.20M to $183.40M. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -36.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
A universal metric for assessing a company's immediate financial health.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $458.10M | $2.03B | $224.70M | $200.90M | $223.60M | $241.70M | $285.20M | $232.50M | $164.10M | $412.60M | $216.80M | $201.00M | $181.90M | $468.20M | $169.90M | $195.20M | $189.00M | $189.00M | $180.80M | $183.40M |
| QoQ Change | — | +342.2% | -88.9% | -10.6% | +11.3% | +8.1% | +18.0% | -18.5% | -29.4% | +151.4% | -47.5% | -7.3% | -9.5% | +157.4% | -63.7% | +14.9% | -3.2% | +0.0% | -4.3% | +1.4% |
| YoY Change | — | — | — | — | -51.2% | -88.1% | +26.9% | +15.7% | -26.6% | +70.7% | -24.0% | -13.5% | +10.8% | +13.5% | -21.6% | -2.9% | +3.9% | -59.6% | +6.4% | -6.0% |